Arginyl-Glutamine
Arginyl-Glutamine is a dipeptide that can decrease VEGF levels and inhibit retinal neovascularization in a mouse model of oxygen-induced retinopathy[1].
Product Specifications
CAS Number
[2483-17-2]
Product Name Alternative
H-Arg-Gln-OH
UNSPSC
12352209
Target
VEGFR
Type
Peptides
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/arginyl-glutamine.html
Solubility
10 mM in DMSO
Smiles
N=C(N)NCCC[C@H](N)C(N[C@H](C(O)=O)CCC(N)=O)=O
Molecular Formula
C11H22N6O4
Molecular Weight
302.33
References & Citations
[1]Neu J, et al. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2006 Jul;47 (7) :3151-5.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P4253/Arginyl-Glutamine-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P4253/
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2066303-01 0.1 mL
FITC-Linked Polyclonal Antibody to Glucosidase Beta, Acid (GbA)
Ask
View Details MBS2066303-02 0.2 mL
FITC-Linked Polyclonal Antibody to Glucosidase Beta, Acid (GbA)
Ask
View Details 
MBS2066303-03 0.5 mL
FITC-Linked Polyclonal Antibody to Glucosidase Beta, Acid (GbA)
Ask
View Details